Breaking News Instant updates and real-time market news.

SRDX

Surmodics

$59.55

-0.25 (-0.42%)

07:39
08/06/18
08/06
07:39
08/06/18
07:39

Surmodics raises FY18 EPS view to 39c-44c from (6c)-9c, consensus (16c)

Raises FY18 revenue view to $79M-$81M from $75M-$79M, consensus $76.8M.

  • 06

    Aug

  • 14

    Aug

  • 15

    Aug

  • 21

    Aug

  • 22

    Aug

SRDX Surmodics
$59.55

-0.25 (-0.42%)

05/02/18
LSCM
05/02/18
NO CHANGE
Target $76
LSCM
Buy
Surmodics price target raised to $76 from $38 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for Surmodics (SRDX) to $76 from $38, citing the company's "solid" Q2 results, guidance for FY18 and the strategic agreement with Abbott (ABT, which he believes is a "game changer." The analyst reiterates a Buy rating on Surmodics shares.
05/03/18
LSCM
05/03/18
NO CHANGE
Target $76
LSCM
Buy
Surmodics price target raised to $76 from $38 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for Surmodics (SRDX) to $76 after reconsidering the way he values the shares. The existing business is worth what the stock is trading for today, and SurVeil, the two other "high potential" products considered in the Abbott (ABT) agreement and the roughly 15 510 (K) products Surmodics is developing are worth about the same, O'Neil tells investors in a research note following the company's Q2 results. He keeps a Buy rating on the shares.
05/03/18
BRRR
05/03/18
NO CHANGE
Target $43
BRRR
Outperform
Surmodics price target raised to $43 from $38 at Barrington
Barrington analyst Michael Petusky raised his price target for Surmodics to $43 following the company's better than expected Q2 results. The analyst's sum-of-the parts methodology assigns $22.50 per share for the core business, $15.25 for the SurVeil DCB program with Abbott and adds $5.25 per share for the net cash on the balance sheet. He keeps an Outperform rating on the name.
05/16/18
NEED
05/16/18
NO CHANGE
Target $55
NEED
Buy
Surmodics price target raised to $55 from $46 at Needham
Needham analyst Mike Matson raised his price target on Surmodics to $55 after its announcement to acquire Embolitech's thrombectomy technology and associated intellectual property, saying the assets will "further strengthen its whole-product solutions pipeline". Matson also keeps his Buy rating on Surmodics, forecasting its Thrombomatrix share of the $500M thrombectomy market to reach $20M by 2021.

TODAY'S FREE FLY STORIES

FB

Facebook

$165.22

3.63 (2.25%)

, SPOT

Spotify

$144.16

2.565 (1.81%)

15:51
03/20/19
03/20
15:51
03/20/19
15:51
On The Fly
#SocialStocks: Facebook downgraded to cap rough week »

Welcome to…

FB

Facebook

$165.22

3.63 (2.25%)

SPOT

Spotify

$144.16

2.565 (1.81%)

AAPL

Apple

$188.13

1.56 (0.84%)

SNAP

Snap

$10.93

0.3 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

WTW

WW

$19.50

-0.34 (-1.71%)

15:50
03/20/19
03/20
15:50
03/20/19
15:50
Conference/Events
WW management to meet with Oppenheimer »

Meeting to be held New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 28

    May

WMT

Walmart

$98.64

-1.25 (-1.25%)

15:49
03/20/19
03/20
15:49
03/20/19
15:49
Periodicals
Breaking Periodicals news story on Walmart »

Walmart CTO leaving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

WIFI

Boingo Wireless

$20.68

-0.25 (-1.19%)

15:41
03/20/19
03/20
15:41
03/20/19
15:41
Conference/Events
Boingo Wireless management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 28

    May

C

Citi

$65.04

-0.59 (-0.90%)

15:40
03/20/19
03/20
15:40
03/20/19
15:40
Periodicals
Citi plans to sell Venezuelan gold placed as collateral, Reuters says »

Citigroup intends to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Apr

  • 16

    Apr

  • 28

    May

  • 13

    Jul

EVER

EverQuote

$7.70

(0.00%)

15:40
03/20/19
03/20
15:40
03/20/19
15:40
Conference/Events
EverQuote management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

CASY

Casey's General Stores

$127.10

0.55 (0.43%)

15:40
03/20/19
03/20
15:40
03/20/19
15:40
Options
Call spreads and put spreads in Caseys General Stores »

Call spreads and put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 03

    Apr

LRAD

LRAD Corporation

$2.82

-0.03 (-1.05%)

15:39
03/20/19
03/20
15:39
03/20/19
15:39
Conference/Events
LRAD Corporation management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

KAMN

Kaman

$57.82

0.325 (0.57%)

15:38
03/20/19
03/20
15:38
03/20/19
15:38
Periodicals
Kaman exploring sale of distribution segment, Bloomberg says »

The company's KDG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

PVTL

Pivotal Software

$19.94

-0.02 (-0.10%)

15:36
03/20/19
03/20
15:36
03/20/19
15:36
Options
Calls lead puts 25:1 in Pivotal Software »

Calls lead puts 25:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

SYX

Systemax

$21.53

0.23 (1.08%)

15:35
03/20/19
03/20
15:35
03/20/19
15:35
Conference/Events
Systemax management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

WSM

Williams-Sonoma

$57.40

0.61 (1.07%)

15:34
03/20/19
03/20
15:34
03/20/19
15:34
Options
Williams Sonoma options imply 10.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

SCS

Steelcase

$15.43

-2.055 (-11.75%)

15:34
03/20/19
03/20
15:34
03/20/19
15:34
Conference/Events
Steelcase management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 25

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

15:30
03/20/19
03/20
15:30
03/20/19
15:30
General news
Powell on the maturity distribution of the portfolio: »

Powell on the maturity…

VLKAY

Volkswagen

$0.00

(0.00%)

15:25
03/20/19
03/20
15:25
03/20/19
15:25
Periodicals
Volkswagen management not yet aligned on restructuring plans, Reuters says »

Volkswagen's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
03/20/19
03/20
15:20
03/20/19
15:20
General news
Powell on the balance sheet: »

Powell on the balance…

15:20
03/20/19
03/20
15:20
03/20/19
15:20
General news
Powell on Brexit »

Powell on Brexit: he hope…

WPM

Wheaton Precious Metals

$23.12

0.385 (1.69%)

15:19
03/20/19
03/20
15:19
03/20/19
15:19
Options
Wheaton Precious Metals options imply 6.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/20/19
03/20
15:17
03/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/20/19
03/20
15:16
03/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
03/20/19
03/20
15:15
03/20/19
15:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

AMZN

Amazon.com

$1,793.67

31.22 (1.77%)

15:11
03/20/19
03/20
15:11
03/20/19
15:11
Hot Stocks
Amazon.com announces launch of MLB.TV on Prime Video Channels »

Amazon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

UNIT

Uniti Group

$9.94

0.08 (0.81%)

15:04
03/20/19
03/20
15:04
03/20/19
15:04
Options
Uniti Group options imply 6.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVS

Novartis

$93.75

0.76 (0.82%)

15:01
03/20/19
03/20
15:01
03/20/19
15:01
Periodicals
Novartis CEO wants to move towards 'transformational innovation,' Fortune says »

Novartis CEO Vasant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.06

0.58 (0.21%)

15:00
03/20/19
03/20
15:00
03/20/19
15:00
General news
Fed chair Powell says he thinks 'deficits matter' »

Federal Reserve chairman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.06

0.58 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.